Best overall response among patients with R/R FL
| Best Overall Response . | All patients with FL N = 48 . |
|---|---|
| ORR∗, % (95% CI) | 52.1 (37.2-66.7) |
| Best response, n (%) | |
| CR | 8 (16.7) |
| PR | 17 (35.4) |
| SD | 11 (22.9) |
| PD | 11 (22.9) |
| NE | 1 (2.1) |
| Best Overall Response . | All patients with FL N = 48 . |
|---|---|
| ORR∗, % (95% CI) | 52.1 (37.2-66.7) |
| Best response, n (%) | |
| CR | 8 (16.7) |
| PR | 17 (35.4) |
| SD | 11 (22.9) |
| PD | 11 (22.9) |
| NE | 1 (2.1) |
Data cutoff of 27 January 2025.
CR, complete response; FL, follicular lymphoma; NE, not evaluable; PD, progressive disease; PR, partial response; SD, stable disease
ORR is defined as the number of patients with best response of CR or PR divided by the total number of patients; 1 patient with a best response of NE is included in the denominator.